BOSTON SCIENTIFIC CORPORATION Goodwill, Acquired During Period
BOSTON SCIENTIFIC CORPORATION (BSX) reported Goodwill, Acquired During Period of $378.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2026-08-03
- BOSTON SCIENTIFIC CORPORATION goodwill, acquired during period for the quarter ending 2026-06-30 was $104.00M, a 83.95% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION goodwill, acquired during period for the quarter ending 2026-03-31 was $274.00M, a 33.66% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION goodwill, acquired during period for the quarter ending 2025-12-31 was $52.00M, a 97.59% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION goodwill, acquired during period for the quarter ending 2025-09-30 was $155.00M, a 72.42% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION goodwill, acquired during period for fiscal 2025 was $1.06B, a 61.97% decline from fiscal 2024.
- BOSTON SCIENTIFIC CORPORATION goodwill, acquired during period for fiscal 2024 was $2.79B, a 92.61% increase from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION goodwill, acquired during period for fiscal 2023 was $1.45B, a 40.49% increase from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION goodwill, acquired during period for fiscal 2022 was $1.03B, a 50.10% decline from fiscal 2021.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | $104.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $378.00M 10-Q · filed 2026-08-03 | $430.00M derived: sum of 3 quarters · filed 2026-08-03 | $585.00M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $274.00M 10-Q · filed 2026-05-01 | $326.00M derived: sum of 2 quarters · filed 2026-05-01 | $481.00M derived: sum of 3 quarters · filed 2026-05-01 | $1.13B derived: sum of 4 quarters · filed 2026-05-01 |
| 2025-12-31 | $52.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $207.00M derived: sum of 2 quarters · filed 2026-02-17 | $855.00M derived: sum of 3 quarters · filed 2026-02-17 | $1.06B 10-K · filed 2026-02-17 |
| 2025-09-30 | $155.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $803.00M derived: sum of 2 quarters · filed 2025-11-03 | $1.01B 10-Q · filed 2025-11-03 | $3.16B derived: sum of 4 quarters · filed 2026-02-17 |
| 2025-06-30 | $648.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $853.00M 10-Q · filed 2025-08-01 | $3.01B derived: sum of 3 quarters · filed 2026-02-17 | $3.57B derived: sum of 4 quarters · filed 2026-02-17 |
| 2025-03-31 | $205.00M 10-Q · filed 2025-05-01 | $2.36B derived: sum of 2 quarters · filed 2026-02-17 | $2.92B derived: sum of 3 quarters · filed 2026-02-17 | $2.97B derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | $2.15B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.72B derived: sum of 2 quarters · filed 2026-02-17 | $2.76B derived: sum of 3 quarters · filed 2026-02-17 | $2.79B 10-K · filed 2026-02-17 |
| 2024-09-30 | $562.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $609.00M derived: sum of 2 quarters · filed 2024-11-01 | $633.00M 10-Q · filed 2024-11-01 | $1.36B derived: sum of 4 quarters · filed 2025-02-18 |
| 2024-06-30 | $47.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $71.00M 10-Q · filed 2024-08-01 | $801.00M derived: sum of 3 quarters · filed 2025-02-18 | $804.00M derived: sum of 4 quarters · filed 2025-02-18 |
| 2024-03-31 | $24.00M 10-Q · filed 2024-05-01 | $754.00M derived: sum of 2 quarters · filed 2025-02-18 | $757.00M derived: sum of 3 quarters · filed 2025-02-18 | $1.14B derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-12-31 | $730.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $733.00M derived: sum of 2 quarters · filed 2025-02-18 | $1.11B derived: sum of 3 quarters · filed 2025-02-18 | $1.45B 10-K · filed 2025-02-18 |
| 2023-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $381.00M derived: sum of 2 quarters · filed 2023-11-01 | $717.00M 10-Q · filed 2023-11-01 | $717.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2023-06-30 | $378.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $714.00M 10-Q · filed 2023-08-03 | $714.00M derived: sum of 3 quarters · filed 2024-02-20 | $755.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2023-03-31 | $336.00M 10-Q · filed 2023-05-04 | $336.00M derived: sum of 2 quarters · filed 2024-02-20 | $377.00M derived: sum of 3 quarters · filed 2024-02-20 | $378.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $41.00M derived: sum of 2 quarters · filed 2024-02-20 | $42.00M derived: sum of 3 quarters · filed 2024-02-20 | $1.03B 10-K · filed 2024-02-20 |
| 2022-09-30 | $41.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $42.00M derived: sum of 2 quarters · filed 2022-11-03 | $1.03B 10-Q · filed 2022-11-03 | $1.20B derived: sum of 4 quarters · filed 2023-02-23 |
| 2022-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $989.00M 10-Q · filed 2022-08-04 | $1.16B derived: sum of 3 quarters · filed 2023-02-23 | $2.13B derived: sum of 4 quarters · filed 2023-02-23 |
| 2022-03-31 | $988.00M 10-Q · filed 2022-05-05 | $1.16B derived: sum of 2 quarters · filed 2023-02-23 | $2.13B derived: sum of 3 quarters · filed 2023-02-23 | $2.13B derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-12-31 | $174.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.14B derived: sum of 2 quarters · filed 2023-02-23 | $1.14B derived: sum of 3 quarters · filed 2023-02-23 | $2.06B 10-K · filed 2023-02-23 |
| 2021-09-30 | $964.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $966.00M derived: sum of 2 quarters · filed 2021-11-04 | $1.89B 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $926.00M 10-Q · filed 2021-08-06 | ||
| 2021-03-31 | $924.00M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $94.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $1.68B derived: sum of 2 quarters · filed 2021-02-23 | $1.95B derived: sum of 3 quarters · filed 2021-02-23 | $2.22B 10-K · filed 2021-02-23 |
| 2019-09-30 | $1.58B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.85B derived: sum of 2 quarters · filed 2019-11-05 | $2.12B 10-Q · filed 2019-11-05 | $2.45B derived: sum of 4 quarters · filed 2020-02-25 |
| 2019-06-30 | $269.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $540.00M 10-Q · filed 2019-07-30 | $863.00M derived: sum of 3 quarters · filed 2020-02-25 | $1.21B derived: sum of 4 quarters · filed 2020-02-25 |
| 2019-03-31 | $271.00M 10-Q · filed 2019-04-29 | $594.00M derived: sum of 2 quarters · filed 2020-02-25 | $940.00M derived: sum of 3 quarters · filed 2020-02-25 | $1.21B derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-12-31 | $323.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $669.00M derived: sum of 2 quarters · filed 2020-02-25 | $939.00M derived: sum of 3 quarters · filed 2020-02-25 | $942.00M 10-K · filed 2020-02-25 |
| 2018-09-30 | $346.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | $616.00M derived: sum of 2 quarters · filed 2018-10-29 | $619.00M 10-Q · filed 2018-10-29 | $736.00M derived: sum of 4 quarters · filed 2019-02-19 |
| 2018-06-30 | $270.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $273.00M 10-Q · filed 2018-07-31 | $390.00M derived: sum of 3 quarters · filed 2019-02-19 | $396.00M derived: sum of 4 quarters · filed 2019-02-19 |
| 2018-03-31 | $3.00M 10-Q · filed 2018-05-01 | $120.00M derived: sum of 2 quarters · filed 2019-02-19 | $126.00M derived: sum of 3 quarters · filed 2019-02-19 | |
| 2017-12-31 | $117.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $123.00M derived: sum of 2 quarters · filed 2019-02-19 | $308.00M 10-K · filed 2019-02-19 | |
| 2017-09-30 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $191.00M 10-Q · filed 2017-11-02 | ||
| 2017-06-30 | $185.00M 10-Q · filed 2017-08-03 | |||
| 2016-12-31 | $185.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $208.00M 10-K · filed 2018-02-20 | ||
| 2016-09-30 | $23.00M 10-Q · filed 2016-11-03 | |||
| 2015-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $543.00M derived: sum of 2 quarters · filed 2017-02-23 | $573.00M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $538.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $568.00M 10-Q · filed 2015-11-04 | ||
| 2015-06-30 | $30.00M 10-Q · filed 2015-08-06 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $169.00M derived: sum of 2 quarters · filed 2016-02-24 | $207.00M derived: sum of 3 quarters · filed 2016-02-24 | $213.00M 10-K · filed 2016-02-24 |
| 2014-09-30 | $169.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $207.00M derived: sum of 2 quarters · filed 2014-11-05 | $213.00M 10-Q · filed 2014-11-05 | $353.00M derived: sum of 4 quarters · filed 2015-02-25 |
| 2014-06-30 | $38.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $44.00M 10-Q · filed 2014-08-06 | $184.00M derived: sum of 3 quarters · filed 2015-02-25 | $184.00M derived: sum of 4 quarters · filed 2015-02-25 |
| 2014-03-31 | $6.00M 10-Q · filed 2014-05-08 | $146.00M derived: sum of 2 quarters · filed 2015-02-25 | $146.00M derived: sum of 3 quarters · filed 2015-02-25 | $146.00M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-12-31 | $140.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $140.00M derived: sum of 2 quarters · filed 2015-02-25 | $140.00M derived: sum of 3 quarters · filed 2015-02-25 | $140.00M 10-K · filed 2015-02-25 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $0.00 derived: sum of 2 quarters · filed 2013-11-05 | $0.00 10-Q · filed 2013-11-05 | $249.00M derived: sum of 4 quarters · filed 2014-02-26 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $0.00 10-Q · filed 2013-08-07 | $249.00M derived: sum of 3 quarters · filed 2014-02-26 | $248.00M derived: sum of 4 quarters · filed 2014-02-26 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-07 | $249.00M derived: sum of 2 quarters · filed 2014-02-26 | $248.00M derived: sum of 3 quarters · filed 2014-02-26 | |
| 2012-12-31 | $249.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $248.00M derived: sum of 2 quarters · filed 2014-02-26 | $563.00M 10-K · filed 2014-02-26 | |
| 2012-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $314.00M 10-Q · filed 2012-11-06 | ||
| 2012-06-30 | $315.00M 10-Q · filed 2012-08-07 | |||
| 2011-12-31 | $266.00M 8-K · filed 2013-05-29 | |||
| 2010-12-31 | $73.00M 10-K · filed 2012-02-17 | |||
| 2009-12-31 | $4.00M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |